Type IV collagen is one of the principal components of renal extracellular matrix; it is released from the glomerular and tubular basement membranes in renal tissues. 1 Urinary excretion of this molecule increases in accordance with the progression of various renal diseases, as a result of the increase of type IV collagen in the diseased kidney. Recent clinical trials to find a better indicator for diabetic nephropathy have demonstrated that the urinary levels of this collagen reflect precisely the rate of matrix turnover.
radioimmunoassay (RIA) systems to measure human type IV collagen have been used in clinical investigations, 15, 16 but there have been no practical systems to measure mouse type IV collagen adaptable to small urine volumes. A commercial ELISA kit now available to measure mouse type IV collagen is based on competitive assay. In general, non-competitive (sandwich type) immunoassay shows lower detection limit than that in competitive immunoassay. 17, 18 Yuen et al. have reported that time-resolved fluoroimmunoassay (TR-FIA) using 4,4′-bis(1″,1″,1″,2″,2″,3″,3″-heptafluoro-4″,6″-hexanedione-6″-yl)-chlorosulfo-o-terphenyl (BHHCT) shows a lower detection limit than other conventional immunoassays. 19 In the present study, in order to reflect accurately renal damage in experimental mouse models, we attempted to establish a highly sensitive sandwich type TR-FIA to measure type IV collagen levels in extremely small amounts of mouse urine. Based on the structural features of type IV collagen, we pretreated samples with dithiothreitol (DTT) to reduce the number of intermolecular disulfide bridges. The reduction enabled us to measure mouse type IV collagen more accurately without requiring a large amount of urine volumes.
This study showed the usefulness of this new system by comparing the urinary levels of type IV collagen both in KK/Ta mice (a diabetic strain spontaneously exhibiting type 2 diabetes) 20 and in non-diabetic BALB/c mice in terms of comparison with a commercial competitive ELISA.
Materials and Methods

Experimental animals
This animal study was conducted in accordance with the guidelines of the animal facility of Juntendo University. In this study, only male mice were used, and all mice were kept in the same room under conventional conditions with a regular light cycle of 12 h light/12 h darkness, and the temperature controlled at 24 ± 1˚C. Two inbred mice strains, KK/Ta and BALB/c, were purchased at the age of four weeks from CLEA Japan Inc. (Tokyo, Japan).
From six weeks onward, mice were individually housed in plastic cages with free access to food (rodent pellet chow CE-2; 342.2 kcal/100 g, containing 4.4% crude fat) and water throughout the experimental period. All phenotypic values, evaluated at the age of 20 weeks, revealed KK/Ta mice to be fully diabetic. Urine samples were collected repeatedly for 10 days because a large urine volume was required for the comparison. Glucose tolerance was assessed using the intraperitoneal glucose tolerance test (IPGTT) for mice. IPGTT was performed by injecting glucose (2 g/kg in 20% solution) intraperitoneally in overnight-fasted mice. Glucose levels in blood obtained from the retro-orbital sinus were measured using an instrument (Glutest E, Kyoto Daiichi Kagaku, Kyoto, Japan) at 0 (fasting blood glucose levels) and 120 min after intraperitoneal glucose injection. Body weight was also checked.
Antibodies and antigens
Rabbit polyclonal anti-mouse type IV collagen antibody was purchased from NOVOTEC (St Martin La Garenne, France). Biotinylated goat polyclonal anti-human type IV collagen antibody, which crossreacts with mouse type IV collagen, was obtained from Abcam Limited (Cambridge, UK). Type IV collagen from Engelbreth-Holm-Swarm transplantable mouse tumor (Sigma-Aldrich Corp., St. Louis, MO, USA) was used as a standard antigen.
Labeling of streptavidin with 4,4′-bis(1″,1″,1″,2″,2″,3″,3″-heptafluoro-4″,6″-hexanedione-6″-yl)-chlorosulfo-o-terphenyl (BHHCT)
Streptavidin was obtained from Chemicon International Inc. (Temecula, CA, USA). The streptavidin-BSA conjugate (SA-BSA) was prepared as reported previously. 21 The SA-BSA conjugate was labeled with a new chelate, BHHCT, as described previously. 21 The solution was diluted to 1:700 by adding 0.05 M Tris-HCl buffer (pH 7.8) containing 1.0 × 10 -7 M EuCl3, 0.2% BSA, 0.1% NaN3 and 0.9% NaCl, and was reacted at 56˚C for 2 h prior to use in the immunoassay.
Measurement of mouse urinary type IV collagen using the timeresolved fluoroimmunoassay (TR-FIA)
Microtiter plates (Nalge Nunc International, NY, USA) were containing 0.2% BSA, 0.1% NaN3 and 0.9% NaCl, was added into the wells of a microtiter plate for fluorometry. After incubation at 5˚C overnight, the wells were washed 3 times with Tris-HCl buffer containing 0.05% Tween 20, and 50 µl of the biotinylated anti type IV collagen antibody (1:300 diluted) was added. After incubation at 5˚C overnight, 50 µl of the BHHCTEu 3+ labeled SA-BSA conjugate (SA-BSA-BHHCT-Eu 3+ ) solution was added, and the material was incubated at 37˚C for 1 h. Finally, the wells were washed 3 times with Tris-HCl buffer (pH 9.1) containing 0.05% Tween 20, and the plate was subjected to solid-phase fluorometric measurement, because this measurement proved to be better than solution-phase. 19 Timeresolved fluorometric measurement at 615 nm was performed using an Arvo SX multilabel counter (PerkinElmer Life Sciences, Boston, MA, USA), with excitation at 340 nm, delay time of 0.2 ms, and window time of 0.4 ms.
Measurement of mouse urinary type IV collagen using competitive ELISA
Urinary type IV collagen was measured by the competitive ELISA (Collagen IV M kit, Exocell Inc., Philadelphia, PA, USA). The assay was performed according to the directions included with the kit, and 240 µl of urine samples was used.
Creatinine assay
Urinary creatinine was measured using a commercial kit (Creatinine Companion, Exocell Inc., Philadelphia, PA, USA) for concentration adjustment of urine samples.
Northern blot analysis for mRNA of type IV collagen
Probes used for Northern blot analysis were prepared as reported previously. 22 Total RNA isolation from whole kidneys of KK/Ta and BALB/c mice at the age of 20 weeks was performed using Trizol (Invitrogen corp., Carlsbad, CA, USA). RNA (10 µg) was electrophoresed on 1.5% agarose and transferred to the nylon membrane. The membrane was prehybridized for 4 h, and then hybridized with 32 P-labeled cDNA probes for the α 1 chain of mouse type IV collagen and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) overnight. After washing, the membrane was exposed to an image plate (Fuji Photo Film Co., Ltd., Tokyo, Japan). The intensity of bands on the image plate was quantified by densitometric scanning model of BAStation 2500 (Fuji Photo Film Co., Ltd., Tokyo, Japan). Finally, adjustment of intensity of α1 chain bands was performed at the GAPDH band intensities.
Statistical analysis
Data were expressed as means ± SD. Statistical significance between the two different mice strains was determined by the Mann-Whitney U test. Regression-correlation analysis in between ELISA and TR-FIA was done using Spearman's test. P values of less than 0.05 were regarded as significant.
Results
Comparison of detection limits between competitive ELISA and sandwich type TR-FIA
The calibration curves of mouse type IV collagen obtained by competitive ELISA and by sandwich type TR-FIA are shown in Fig. 1 . The detection limit (dl) of type IV collagen using our assay was 0.1 ng/ml when calculated by the following formula: dl = 3SD·C/I-I0 (SD: the standard deviation of the background signal, C: the lowest measured concentration with its signal intensity I, I0: the background signal). 23 The mean coefficient of intra-assay variation was 4.2% (0.4 -7.4% at 8 different concentrations). The detection limit (100 pg/ml) is about 1/100 lower than that of competitive ELISA. To obtain recoveries of standard antigens to urine specimens, 1:5 diluted human urine was used as a diluent. Five different concentrations of standard mouse type IV collagen (2.5, 10, 40, 160, and 320 ng/ml) in the diluted human urine were assayed (data not shown Fig. 2A . The correlation after addition of DTT (2 mM) was shown in Fig. 2B . Each point represents the mean ± SD from three experiments. Fig. 3 Effect of DTT concentration on urine (Fig. 3A) and standard solutions (Fig. 3B) . Urine samples from KK/Ta mice and standard solution were incubated with equal volumes of 0, 2, and 5 mM DTT. recovery of mouse type IV collagen added to human urine samples was more than 95% at each concentration.
Analysis of diluted mouse urine samples
Using urine samples from diabetic KK/Ta and non-diabetic BALB/c mice at the age of 20 weeks, correlation between the dilution rate of urine and fluorescence intensity was investigated (Fig. 2) . The urine samples of each strain (n = 3) were diluted with 0.05 M Tris-HCl buffer (pH 7.8) containing 0.2% BSA, 0.1% NaN3 and 0.9% NaCl. When the samples were assayed without pretreatment, fluorescence intensity decreased from dilution 1:20 to 1:2 (shown by open squares) as shown in Fig.  2A . The decrease was more significant in KK/Ta mice than in BALB/c mice. As shown in Fig. 2B , pretreatment by addition of DTT to urine samples showed a positive correlation between the dilution rate of urine and fluorescence intensity in both strains.
Optimal condition of DTT pretreatment for measuring urinary type IV collagen
In order to establish optimal conditions for the measurement, the effect of DTT concentration in the pretreatment of urine samples was examined (Fig. 3A) . DTT concentration was varied (1, 2, and 5 mM). Standard antigen was also treated in the same manner (Fig. 3B) . In both assays, standard solution was little affected at 2 mM DTT, and the optimal concentration for the pretreatment was 2 mM. By pretreatment with DTT at a concentration of 2 mM, a correlation between dilution rate of urine and fluorescence intensity was observed in KK/Ta mice (Fig. 3A) .
To check cross-reactivity with other type collagens such as mouse type I and II collagens, both type collagens were also treated with 2 mM DTT. Cross-reactions with these type collagens were not observed (not shown in figure) , confirming the specificity of type IV collagen.
Glucose tolerance test and body weight of KK/Ta and BALB/c mice
As shown in Table 1 , KK/Ta mice at the age of 20 weeks showed fasting hyperglycemia and impaired glucose tolerance as well as obesity, compared with the findings in the normal control BALB/c mice at the age of 20 weeks (p < 0.01).
Concentration of mouse urinary type IV collagen in two mice strains using sandwich type TR-FIA and conventional competitive immunoassay
To investigate the usefulness of our assay, concentration of urinary type IV collagen in diabetic KK/Ta and non-diabetic BALB/c mice at the age of 20 weeks was measured by both our TR-FIA and a commercially available competitive ELISA (Fig.  4) . In each immunoassay, a higher concentration was observed in KK/Ta mice than in BALB/c mice (p < 0.01), but the range of the concentration in TR-FIA was much higher than that in the competitive ELISA. Furthermore, in TR-FIA the difference of the values between KK/Ta and BALB/c mice was greater than in competitive ELISA. A positive correlation was shown between these assays (correlation coefficient = 0.607, p value = 0.034)
Northern blot analysis
As shown in Fig. 5 , mRNA expression of type IV collagen increased more significantly in KK/Ta mice than in BALB/c mice. Densitometric scanning showed that mRNA expression of the α1 chain was 11.1 times higher in KK/Ta mouse than in BALB/c mouse.
Disucussion
Several studies have reported increased production of type IV collagen in diseased kidneys. 2, 15, 24 Although these reports suggest that increased urinary type IV collagen is a more reliable indicator of early renal dysfunction than other urinary proteins, there has been no highly sensitive assay method for a very small volume of urine samples such as those obtained from rodents. Currently used conventional ELISA requires a large sample volume (240 µl), but mouse urine, generally a very small quantity in each excretion, is difficult to collect. However, our TR-FIA was found to be applicable to measurement of urinary type IV collagen in extremely small samples.
Type IV collagen is a large molecule having several structural features. According to gel chromatographic analysis, type IV collagen in urine samples has a maximal peak at 340 kDa. 3 As mentioned above, this large molecule consists of polymer units, each with many disulfide bridges as major bonds. [7] [8] [9] [10] [11] [12] [13] In our earlier assay without DTT pretreatment, fluorescence intensity at the low dilution rate of urine was not proportionate to the amount of type IV collagen in the two strains ( Fig. 2A) , where a larger amount of collagen excretion was expected in KK/Ta mouse urine. This lack of correlation appeared to be caused by interference of the antigen-antibody reaction, sterically hindered by a macromolecular network of self-aggregating properties.
Kleinmann IV collagen from an Engelbreth-Holm-Swarm mouse tumor using 2 mM DTT and 2 mM guanidine. 25 DTT is a reductant widely used for pretreatment of samples before antigenantibody reactions on membranes in Western blotting. We attempted to reduce the molecular size of urinary type IV collagen to an appropriate size in order to recognize surface epitopes, which were fully exposed to the antibody by reducing many disulfide bridges with DTT. As expected, pretreatment by addition of DTT to urine samples showed a positive correlation between the dilution rate of urine and fluorescence intensity in TR-FIA (Fig. 2B) . The result seems to indicate that pretreatment exposed more epitopes in a collagen molecule and also that epitopes easily bound to antibody. Disulfide bridges are generally considered to serve as a part of intermolecular and intramolecular bonds, which are associated with conformation of the type IV collagen molecule. Addition of more than 2 mM DTT to the standard solution did not give a better result (Fig.  3B ), which suggests that excessive pretreatment might destroy the important conformation of epitopes in the antigen. To confirm the findings on the antigen change, the determination of molecular size of urinary type IV collagen with DTT pretreatment is now under study. Although our assay with pretreatment and competitive ELISA using a commercial kit showed the same tendency with the concentration of urinary type IV collagen in KK/Ta mice higher than that in BALB/c mice, several clear differences were observed in these immunoassays.
First, the range of the concentration in our assay was nearly one hundred times higher than that in the competitive ELISA. This may be attributed to the following differences: assay methods, antibodies used and addition of DTT, which increased the exposed epitopes in a collagen molecule. The increase caused by DTT might contribute to further enhancement of the difference between KK/Ta and BALB/c mice in our TR-FIA more than in competitive ELISA. Northern blot analysis showed that mRNA expression of type IV collagen increased much more in KK/Ta mouse than in BALB/c mouse, which is consistent with the results in these immunoassays. Our assay requires only 5 µl of urine samples, while competitive ELISA requires as much as 240 µl. The small sample volume required in our assay is partially due to pretreatment using DTT.
In this study, we have described a highly sensitive sandwichtype TR-FIA to measure mouse urinary type IV collagen, one of the most useful indicators for early renal damage. This assay not only enables measurement of even a small volume of samples but also clarifies differences in values between the mouse strains without cross-reactivity to other type collagens.
We believe this assay can provide a better evaluation of earlier renal damage in experimental mice model than currently common assays with proteins, such as albumin, as an indicator. The next step is to reveal how precisely urinary levels of type IV collagen obtained by this assay are related to the histopathological (immunohistochemical and morphometrically analytic) findings in diseased murine kidney.
